Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Capital Expenditures (2016 - 2024)

Historic Capital Expenditures for ProPhase Labs (PRPH) over the last 15 years, with Q4 2024 value amounting to $40000.0.

  • ProPhase Labs' Capital Expenditures fell 8326.36% to $40000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $40000.0, marking a year-over-year decrease of 9638.01%. This contributed to the annual value of $906000.0 for FY2024, which is 5652.59% down from last year.
  • Per ProPhase Labs' latest filing, its Capital Expenditures stood at $40000.0 for Q4 2024, which was down 8326.36% from -$1000.0 recorded in Q3 2024.
  • In the past 5 years, ProPhase Labs' Capital Expenditures ranged from a high of $3.9 million in Q1 2021 and a low of -$446000.0 during Q2 2023
  • In the last 5 years, ProPhase Labs' Capital Expenditures had a median value of $310000.0 in 2021 and averaged $675210.5.
  • As far as peak fluctuations go, ProPhase Labs' Capital Expenditures soared by 601111.11% in 2022, and later tumbled by 16617.21% in 2023.
  • ProPhase Labs' Capital Expenditures (Quarter) stood at $1.5 million in 2020, then crashed by 101.84% to -$27000.0 in 2021, then surged by 6011.11% to $1.6 million in 2022, then plummeted by 85.03% to $239000.0 in 2023, then crashed by 83.26% to $40000.0 in 2024.
  • Its Capital Expenditures stands at $40000.0 for Q4 2024, versus -$1000.0 for Q3 2024 and $867000.0 for Q1 2024.